K191985

Substantially Equivalent

Optilite IgA Kit

Applicant: The Binding Site Group , Ltd.
Product code: CFN
Advisory panel: Immunology
Date received: 2019-07-25
Decision date: 2019-08-19
Decision: Substantially Equivalent
Clearance type: Special
Location: Edgbaston, GB

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.